<DOC>
	<DOC>NCT01523496</DOC>
	<brief_summary>The purpose of this study is to determine the correct dose of Vitamin D to give to prevent HIV related complications.</brief_summary>
	<brief_title>Vitamin D Supplementation in HIV Youth</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Ages 825 Documented HIV1 infection On stable ART for &gt; 3 months Cumulative ART of at least 6 months 25(OH)D level &lt; 30 ng/ml at screening &gt; 400 IU daily regular vitamin D intake Parathyroid/calcium disorders Active malignancy Pregnancy/intent to become pregnant/breastfeeding Chronic infectious/inflammatory conditions Creatinine clearance &lt; 50 ml/min Hemoglobin &lt; 9.0 g/dL AST and ALT &gt; 2.5 ULN Diabetes requiring hypoglycemic agents Known coronary artery disease Inability to swallow pills</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>HIV</keyword>
	<keyword>Vitamin D Deficiency</keyword>
</DOC>